Hppd variants and methods of use
US-2017166918-A1 · Jun 15, 2017 · US
US11555202B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11555202-B2 |
| Application number | US-201716471776-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 22, 2017 |
| Priority date | Dec 22, 2016 |
| Publication date | Jan 17, 2023 |
| Grant date | Jan 17, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides specific transgenic soybean plants, plant material and seeds, characterized in that these products harbor a specific nematode resistance and herbicide tolerance transformation event at a specific location in the soybean genome. Tools are also provided which allow rapid and unequivocal identification of the event in biological samples.
Opening claim text (preview).
The invention claimed is: 1. A nucleic acid molecule comprising (a) a nucleotide sequence with at least 99% sequence identity to the nucleotide sequence of SEQ ID No. 5, 6, 24 or 25, or to the complement of SEQ ID No. 5, 6, 24 or 25; (b) the nucleotide sequence of SEQ ID No. 1, 2, 3, 4, 5, 6, 24, or 25 or the complement of SEQ ID No. 1, 2, 3, 4, 5, 6, 24, or 25; or (c) the nucleotide sequence of SEQ ID No. 1 or 3 and the nucleotide sequence of SEQ ID No. 2 or 4, or the complement of SEQ ID No. 1 or 3 and the complement of SEQ ID No. 2 or 4. 2. The nucleic acid molecule of claim 1 , further comprising: (a) the nucleotide sequence of SEQ ID No. 7 and 9, or the complement of SEQ ID No. 7 and 9; (b) the nucleotide sequence of SEQ ID No. 11 from nucleotide position 188 to nucleotide position 7368; or (c) a nucleotide sequence having at least 98%, or least 99%, or at least 99.5% or at least 99.9% sequence identity to the nucleotide sequence of (a) or (b). 3. The nucleic acid molecule of claim 2 , wherein the molecule comprises the nucleotide sequence of SEQ ID No. 5 or 24 and SEQ ID No. 6 or 25, or the complement of SEQ ID No. 5 or 24 and SEQ ID No. 6 or 25. 4. A nucleic acid molecule obtainable from the seed deposited at the ATCC under accession number PTA-123625, wherein said nucleic acid molecule comprises the nucleotide sequence of any one of SEQ ID No. 1, 3, or 5 and the nucleotide sequence of any one of SEQ ID No. 2, 4, or 6. 5. Soybean genomic DNA comprising the nucleic acid molecule of claim 1 . 6. A nucleic acid molecule comprising the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941, or a nucleotide sequence having at least 95%, at least 96%, at least 97%, at least 98%, or at least 99% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 7. A nucleic acid molecule that specifically characterizes soybean elite transformation event EE-GM5, wherein it comprises (i) the nucleotide sequence of any one of SEQ ID No. 1, 3, or 5, and/or (ii) the nucleotide sequence of SEQ ID No. 2, 4, or 6. 8. A nucleic acid molecule comprising (a) a nucleotide sequence with at least 98% sequence identity to SEQ ID No. 7 or 9; or (b) a nucleotide sequence with at least 95% sequence identity to SEQ ID No. 11. 9. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises a nucleotide sequence with at least 99% sequence identity to the nucleotide sequence of SEQ ID No. 5, 6, 24 or 25, or to the complement of SEQ ID No. 5, 6, 24 or 25. 10. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 1 or the complement of SEQ ID No. 1. 11. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 2 or the complement of SEQ ID No. 2. 12. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 3 or the complement of SEQ ID No. 3. 13. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 4 or the complement of SEQ ID No. 4. 14. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 5 or the complement of SEQ ID No. 5. 15. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 6 or the complement of SEQ ID No. 6. 16. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 24 or the complement of SEQ ID No. 24. 17. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 25 or the complement of SEQ ID No. 25. 18. The nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 1 or 3 and the nucleotide sequence of SEQ ID No. 2 or 4, or the complement of SEQ ID No. 1 or 3 and the complement of SEQ ID No. 2 or 4. 19. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 20. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 21. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises a nucleotide sequence having at least 96% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 22. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises a nucleotide sequence having at least 97% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 23. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises a nucleotide sequence having at least 98% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 24. The nucleic acid molecule of claim 6 , wherein the nucleic acid molecule comprises a nucleotide sequence having at least 99% sequence identity to the nucleotide sequence of SEQ ID No. 11 from nucleotide position 131 to nucleotide position 7941. 25. The nucleic acid molecule of claim 8 , wherein the nucleic acid molecule comprises a nucleotide sequence with at least 98% sequence identity to SEQ ID No. 7 or 9. 26. The nucleic acid molecule of claim 8 , wherein the nucleic acid molecule comprises a nucleotide sequence with at least 95% sequence identity to SEQ ID No. 11.
for biotic stress resistance, pathogen resistance, disease resistance · CPC title
for herbicide resistance · CPC title
for plants, fungi or algae · CPC title
containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals · CPC title
Expression markers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.